Menu

CBT-I: The First-Line Treatment for Chronic Insomnia (Not Sleeping Pills)
Dr. Michael Zimmer

Dr. Michael A. Zimmer

CBT-I: The First-Line Treatment for Chronic Insomnia (Not Sleeping Pills)

Medically reviewed by Michael A. Zimmer, MD, MACPBoard-Certified Internal Medicine, Medical Director
Post Summary

Cognitive behavioral therapy for insomnia (CBT-I) is more effective than sleeping pills for chronic insomnia and produces lasting results. Learn what CBT-I involves, why pills are not first-line, and how to access this evidence-based treatment.

A Treatment Most Patients Have Never Heard Of

Chronic insomnia affects roughly 10–15 percent of adults. Patients suffer through years of poor sleep, often cycling through prescription sleeping pills and over-the-counter aids that work modestly at best and carry meaningful risks.

Cognitive behavioral therapy for insomnia (CBT-I) is more effective than any sleeping pill for chronic insomnia. The American College of Physicians, the American Academy of Sleep Medicine, and other major societies recommend it as first-line treatment for chronic insomnia. Yet most patients with chronic insomnia have never been offered it — they get prescriptions instead.

At Zimmer Medical Group, we discuss CBT-I as the foundation of insomnia treatment and refer to providers and resources that deliver it.

What Chronic Insomnia Is

Chronic insomnia involves:

  • Difficulty falling asleep, staying asleep, or waking too early
  • Symptoms occurring at least 3 nights per week
  • Symptoms persisting at least 3 months
  • Daytime consequences — fatigue, mood disturbance, concentration problems, reduced performance

Acute insomnia (lasting less than 3 months) often resolves with addressing the precipitating cause. Chronic insomnia tends to perpetuate itself through behavioral and cognitive patterns that benefit from specific intervention.

Why Pills Are Not First-Line

Common sleep medications include:

Benzodiazepines (Temazepam, Lorazepam, Others)

  • Habit-forming with regular use
  • Tolerance develops, requiring higher doses
  • Dependence and difficult discontinuation
  • Increased fall risk in older adults — see our benzodiazepines and older adults article
  • Cognitive impairment, particularly memory
  • Increased dementia risk with long-term use
  • Daytime sedation

Z-Drugs (Zolpidem, Eszopiclone, Zaleplon)

  • Similar concerns to benzodiazepines
  • Sleep-related complex behaviors (driving, eating, walking while asleep — well-documented with zolpidem)
  • Tolerance and dependence
  • Memory effects
  • Increased fall risk
  • Initially marketed as safer than benzodiazepines but evidence has accumulated of similar concerns

Antihistamines (Benadryl, Tylenol PM, Many "Sleep Aids")

  • Diphenhydramine and similar compounds
  • Significant anticholinergic effects
  • Cognitive impairment, particularly in older adults
  • Long-term use associated with increased dementia risk
  • Tolerance to sedative effect develops quickly
  • Can worsen restless legs and other sleep disorders

Melatonin

  • Useful for circadian rhythm disorders and jet lag
  • Modest effect for primary insomnia
  • Generally safe for short-term use
  • Long-term safety data limited
  • Quality of products varies (it's a supplement, not a regulated medication)

Newer Medications

  • Suvorexant, lemborexant, daridorexant — orexin receptor antagonists; less concerning side effect profiles but still recommended as adjunctive rather than first-line
  • Trazodone — used widely off-label; modest evidence; daytime sedation common

The fundamental issue: sleeping pills can help short-term sleep but don't change the underlying patterns driving chronic insomnia. When pills are stopped, symptoms typically return.

What CBT-I Actually Is

CBT-I combines several evidence-based components:

Stimulus Control

  • Use the bed only for sleep and intimacy (not reading, TV, scrolling)
  • Go to bed only when sleepy
  • If unable to sleep within about 20 minutes, get out of bed and do something quiet until sleepy
  • Get up at the same time every morning regardless of sleep quality
  • No daytime napping (or very brief, very early naps)

Sleep Restriction (Sleep Compression)

This is often the most powerful component:

  • Calculate average actual sleep time over 1–2 weeks
  • Restrict time in bed to that amount (with a minimum of 5 hours)
  • This temporarily creates sleep debt, building sleep pressure
  • As sleep efficiency improves, time in bed is gradually extended
  • Often produces dramatic improvement within 2–4 weeks

Cognitive Restructuring

  • Address unhelpful beliefs about sleep
  • "I must get 8 hours or I'll be miserable tomorrow"
  • "If I don't sleep tonight, I'll fall apart"
  • "I have to make up for last night's poor sleep"
  • These thoughts increase arousal and worsen insomnia

Sleep Hygiene Education

  • Comfortable sleep environment
  • Avoid caffeine in the afternoon
  • Limit alcohol (disrupts sleep architecture)
  • Exercise regularly (but not late evening)
  • Wind-down period before bed
  • Address light exposure (bright light morning, dim evening)

See our sleep hygiene article for more detail.

Relaxation Training

  • Progressive muscle relaxation
  • Diaphragmatic breathing
  • Mindfulness-based techniques
  • Address racing mind at bedtime

How CBT-I Works in Practice

A typical CBT-I program:

  • 4–8 sessions over 6–12 weeks
  • Initial assessment
  • Sleep diary tracking throughout
  • Weekly adjustments based on diary data
  • Behavioral changes implemented progressively
  • Cognitive work integrated throughout
  • Tapering of any sleep medications often part of the process

Where to Access CBT-I

In-Person Therapy

  • Behavioral sleep medicine specialists
  • Some psychologists trained in CBT-I
  • Some sleep centers
  • May be limited in availability in some areas

Telehealth CBT-I

  • Increasingly available
  • Same evidence base as in-person
  • More accessible

Digital CBT-I

  • App-based and online programs with strong evidence
  • Sleepio — extensively studied; available in some healthcare systems
  • Somryst — FDA-cleared prescription digital therapeutic
  • CBT-I Coach app — developed by VA; free; effective for many patients
  • Sleep Reset, Restore, others — various commercial options

Digital CBT-I is increasingly viewed as an excellent first-line option, particularly when in-person therapy isn't accessible.

Self-Guided Programs

  • Books like "Quiet Your Mind and Get to Sleep" by Carney and Manber
  • "Say Good Night to Insomnia" by Jacobs
  • Workbooks and structured programs

Self-guided CBT-I works for motivated patients but often less effective than therapist-guided.

What to Expect

The honest realities of CBT-I:

  • Sleep restriction often makes things worse before they get better — patients may feel more tired in the first 1–2 weeks; this is part of the mechanism
  • Improvement typically begins within 2–4 weeks
  • Significant improvement by 6–8 weeks is typical
  • Effects persist long-term — unlike medications, gains tend to be sustained
  • Requires commitment — daily implementation of recommendations
  • Effective for the majority of patients — including those who have failed multiple medications

When Medications Are Reasonable

Despite CBT-I being first-line, medications have a role:

  • Short-term use during acute stress
  • Bridge therapy while accessing CBT-I
  • Patients who can't access CBT-I
  • Selected long-term use in patients who have failed other approaches
  • When combined with CBT-I

The goal should usually be the lowest effective dose for the shortest reasonable duration, with regular reassessment.

Special Considerations

Older Adults

  • Particularly important to avoid Z-drugs and benzodiazepines (fall risk, cognitive effects)
  • CBT-I works as well or better in older adults
  • Address underlying causes (sleep apnea, restless legs, nighttime urination, pain)
  • Address natural age-related changes in sleep architecture

Patients on Existing Sleep Medications

  • CBT-I can include planned medication tapering
  • Don't stop benzodiazepines abruptly
  • Coordinate with prescribing physician
  • See our benzodiazepine deprescribing article

Patients with Coexisting Conditions

CBT-I works for insomnia coexisting with:

  • Depression and anxiety
  • Chronic pain
  • Substance use
  • Other sleep disorders (after addressing primary disorder)

Treating insomnia often improves coexisting conditions too.

What Else to Address

  • Sleep apnea — must be ruled out in patients with insomnia
  • Restless legs syndrome — see our RLS article
  • Mental health conditions — depression, anxiety
  • Pain conditions
  • Medication-related sleep disturbance
  • Substance use — alcohol, caffeine, others
  • Circadian rhythm disorders

When to See Your Doctor

  • Insomnia persisting more than 3 months
  • Daytime impact from poor sleep
  • Insomnia with snoring, gasping, or other features suggesting sleep apnea
  • Insomnia with leg discomfort suggesting restless legs
  • Currently using sleep medications and wanting to consider alternatives
  • Looking for CBT-I resources and referrals

The American Academy of Sleep Medicine and the Society of Behavioral Sleep Medicine provide additional resources for accessing evidence-based insomnia care.


Chronic insomnia not adequately addressed by medications? Contact Zimmer Medical Group for an evaluation, CBT-I referral, and a thoughtful approach to deprescribing sleep medications when appropriate.

Frequently Asked Questions

Because it works better over time. CBT-I matches or exceeds medication during treatment and, unlike medication, its benefit persists after treatment ends. Sleeping pills work while taken and insomnia typically returns when they stop, alongside tolerance and dependence with sustained use.
Usually four to eight sessions covering sleep restriction — deliberately limiting time in bed to consolidate sleep — stimulus control to rebuild the association between bed and sleep, addressing the thoughts that keep you awake, and relaxation training. It is structured and time-limited rather than open-ended therapy.
Yes. Duration is not a strong predictor of response, and people who have had insomnia for decades respond at similar rates to those with recent onset. It also works alongside coexisting depression, anxiety, and chronic pain rather than requiring those to be resolved first.
Digital CBT-I programs have good trial evidence and are considerably more available than trained therapists, who are in short supply almost everywhere. Several validated apps and online programs deliver the same components, and they are a reasonable first step rather than a compromise.